BLENREP
Glaxo Group Limited
| Research |
OneLook
Acronym Finder
|
| Serial Number | 98155191 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Christopher M. Hanes |
| Attorney Docket Number | 84265012 |
Timeline
| 2023-08-29 | Application Filed |
| 2023-09-01 | Location: NEW APPLICATION PROCESSING |
| 2023-09-01 | Status: Live/Pending |
| 2023-09-01 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Glaxo Group Limited |
| Entity Statement | private company limited by shares (prc) |
| Address | GSK Medicines Research Gunnels Wood Rd Stevenage GB SG12NY GB2 |
| Legal Entity Type | |
| Legal Entity State | GB2 |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations and substances for treatment of oncological diseases and disorders |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED | 2023-09-01 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2023-09-26 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2024-03-25 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2024-03-26 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2024-03-26 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2024-03-26 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2024-04-24 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2024-04-24 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2024-04-24 | 9 TEME I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BLENREP 98155191 not registered Live/Pending |
Glaxo Group Limited 2023-08-29 |
 BLENREP 86451001 5258533 Live/Registered |
Glaxo Group Limited 2014-11-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 